Disposition of 572 shares by Sievers Eric of Bioatla at 1.77 subject to Rule 16b-3
BCAB Stock | USD 0.47 0.01 2.17% |
About 59% of Bioatla's investor base is looking to short. The analysis of the overall investor sentiment regarding Bioatla suggests that many traders are alarmed. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
Bioatla |
Filed transaction by Bioatla Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Bioatla Fundamental Analysis
We analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Bioatla is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Bioatla Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioatla stock to make a market-neutral strategy. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics with similar companies.
Peers
Bioatla Related Equities
ACRV | Acrivon Therapeutics, | 4.84 | ||||
GLUE | Monte Rosa | 3.26 | ||||
ADAG | Adagene | 2.70 | ||||
AVTE | Aerovate Therapeutics | 1.55 | ||||
RZLT | Rezolute | 0.77 | ||||
ERAS | Erasca | 0.53 | ||||
IKNA | Ikena Oncology | 0.67 | ||||
PMVP | Pmv Pharmaceuticals | 1.39 | ||||
NRIX | Nurix Therapeutics | 1.55 | ||||
KYMR | Kymera Therapeutics | 2.13 | ||||
DSGN | Design Therapeutics | 2.41 | ||||
ANTX | AN2 Therapeutics | 2.56 | ||||
NAUT | Nautilus Biotechnology | 3.39 | ||||
FHTX | Foghorn Therapeutics | 3.46 | ||||
OLMA | Olema Pharmaceuticals | 3.48 | ||||
IPSC | Century Therapeutics | 3.53 | ||||
PASG | Passage Bio | 4.92 | ||||
CCCC | C4 Therapeutics | 5.71 | ||||
STTK | Shattuck Labs | 7.20 |
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |